Cardlytics, Inc.

CDLX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Market Cap$87,038$94,391$189,229
- Cash$43,961$46,745$52,046$65,594
+ Debt$173,746$220,412$220,726$221,651
Enterprise Value$260,705$263,071$345,286
Revenue$52,031$63,249$61,898$73,997
% Growth-17.7%2.2%-16.4%
Gross Profit$24,300$29,263$25,160$32,733
% Margin46.7%46.3%40.6%44.2%
EBITDA-$63,285$3-$3,983-$6,718
% Margin-121.6%0%-6.4%-9.1%
Net Income-$72,673-$9,283-$13,282-$15,589
% Margin-139.7%-14.7%-21.5%-21.1%
EPS Diluted-1.36-0.18-0.26-0.31
% Growth-655.6%30.8%16.1%
Operating Cash Flow$1,761$1,225-$6,706$2,979
Capital Expenditures-$4,464$0$0-$4,436
Free Cash Flow-$2,703$1,225-$6,706-$1,457
Cardlytics, Inc. (CDLX) Financial Statements & Key Stats | AlphaPilot